Dividend14 Aug 2026, 04:09 pm
Medicamen Biotech Ltd. Approves Dividend Payment, Sets AGM Date
AI Summary
Medicamen Biotech Limited announced that its Board of Directors has approved the closure of its Register of Members and Share Transfer Books from September 19 to September 25, 2026. This closure is in connection with the proposed payment of a final dividend of 10%, or Re. 1/- per equity share, subject to shareholder approval at the upcoming 33rd Annual General Meeting (AGM). The AGM is scheduled for September 26, 2026, at 12:00 PM via Video Conferencing. The company also approved the draft Annual Report and Cost Audit Report for FY 2025-26 and took note of communications from stock exchanges regarding past non-compliance fines.
Key Highlights
- Register of Members and Transfer Books to close Sep 19-25, 2026.
- Proposed final dividend of 10% (Re. 1 per share) subject to member approval.
- 33rd AGM scheduled for September 26, 2026, via VC/OAVM.
- Board approved draft Annual Report and Cost Audit Report for FY 2025-26.
- Noted stock exchange communications regarding past fines.
Price Impact
More from MEDICAMEQ